An Asthma Mobile Intervention to Promote Patient-Reported Outcomes in Primary Care
Purpose
Through this study, the investigators will adapt the ASTHMAXcel mobile app and evaluate the adapted intervention through a randomized controlled trial.
Condition
- Asthma
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
English-speaking individuals >18 years with: 1. persistent asthma(diagnosis made by a healthcare provider) on a daily controller medication 2. able to give informed consent 3. Smartphone (iOS or Android) access
Exclusion Criteria
- use of oral corticosteroids in the 2 weeks prior to the baseline visit 2. pregnancy 3. severe psychiatric or cognitive problems that would prohibit an individual from completing the protocol 4. patients that previously received ASTHMAXcel
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Intervention Model Description
- Through the randomized controlled trial component, there will be 2 arms, which include the ASTHMAXcel intervention and usual care delivered through the outpatient primary care setting.
- Primary Purpose
- Health Services Research
- Masking
- None (Open Label)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental ASTHMAXcel arm |
The ASTHMAXcel arm represents the study intervention, which is a patient-facing mobile application for adult patients with asthma. |
|
|
Active Comparator Usual care arm |
This arm represents usual care delivered in the outpatient primary care setting at the study sites. |
|
More Details
- Status
- Completed
- Sponsor
- Montefiore Medical Center
Study Contact
Detailed Description
Through this study, the investigators will use patient and provider feedback to adapt the ASTHMAXcel mobile intervention, and will conduct a randomized controlled trial to test the intervention's impact on clinical and process outcomes.